pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026
METUCHIN, N.J., Dec. 23, 2025 /PRNewswire/ -- As 2026 approaches, podiatrists, chiropractors, and dentists are facing a rapidly evolving digital...
Day: December 23, 2025
Therap Services Enhances Individual Plan Workflows to Boost Efficiency and Improve User Experience
TORRINGTON, Conn., Dec. 23, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic documentation solutions for organizations in Long-Term...
Bausch Health Announces Final Results and Expiration of Exchange Offers
LAVAL, QC / ACCESS Newswire / December 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") and its subsidiary...
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
SOUTH SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / December 23, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage biopharmaceutical company...
A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors
Franklin, Tennessee--(Newsfile Corp. - December 23, 2025) - From global stages and scientific breakthroughs to philanthropic leadership and international recognition,...
Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026
MILFORD, Mass., Dec. 23, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive...
NAVER D2SF-Backed Startups Participate in “CES 2026”
Five teams won CES Innovation Awards, including one Best of Innovation Award and three double Innovation Award winnersProving technological capabilities...
Next Gen Diagnostics Launches NGD Infection Prevention to Provide Real-Time Transmission Detection
CAMBRIDGE, Mass., Dec. 23, 2025 /PRNewswire/ -- Next Gen Diagnostics (NGD) today announced that January 1 the Company will spin...
Historic $15 Million Gift Fuels Breakthrough Cancer Care at Hartford HealthCare St. Vincent’s Medical Center
The Estate of Neil Mellen Helps Build Destination for Advanced Cancer Care in ConnecticutBRIDGEPORT, Conn., Dec. 23, 2025 /PRNewswire/ -- Hartford...
Patients Turn to AI for Health Research but Remain Cautious of Accuracy and Privacy Risks
New data from Health Union's survey of over 6,000 patients across 49 chronic conditions shows a rise in "AI-first" information-seeking,...
A Slice of Humble Pie: How One Farmer’s Harvest-Time Tradition Is Lifting Up Her Community
Pivot Bio's "Pivotal People Inspired by Real Farm Heroes" Series Spotlights Marilyn Backman and her world-famous piesMINNEAPOLIS, Dec. 23, 2025...
Best Horvath Clock Test (2026): TruDiagnostic Awarded for Accurate GrimAge and PhenoAge Analysis by Better Business Advice
NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Better Business Advice is recognizing TruDiagnostic in its 2026 assessment of Horvath Clock testing solutions....
Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01
Calgary, Alberta--(Newsfile Corp. - December 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or the "Company"),...
LivaNova to Present at J.P. Morgan Healthcare Conference in January
LONDON--(BUSINESS WIRE)--$LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan...
LivaNova to Present at J.P. Morgan Healthcare Conference in January
LONDON--(BUSINESS WIRE)--$LIVN #OSA--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan...
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in...
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026King of Prussia, Pennsylvania--(Newsfile Corp. - December...
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
Nonclinical protocol study design accepted by FDA Study to commence in First Quarter 2026King of Prussia, Pennsylvania--(Newsfile Corp. - December...
LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site
LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Reached Critical Regulatory Milestone with Receipt of...